LBWM
AMGN icon

Left Brain Wealth Management’s Amgen AMGN Stock Holding History

Left Brain Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$584K Sell
1,614
-173
-10% -$59.2K 0.18% 60
2026
Q1 		$629K Sell
1,787
-15
-0.8% -$5.35K 0.25% 50
2025
Q4 		$590K Sell
1,802
-30
-2% -$9.52K 0.2% 54
2025
Q3 		$517K Sell
1,832
-129
-7% -$37.4K 0.16% 71
2025
Q2 		$548K Sell
1,961
-176
-8% -$49.9K 0.19% 61
2025
Q1 		$666K Sell
2,137
-86
-4% -$25.4K 0.29% 53
2024
Q4 		$579K Buy
2,223
+10
+0.5% +$2.97K 0.22% 63
2024
Q3 		$713K Buy
2,213
+118
+6% +$38.6K 0.33% 54
2024
Q2 		$655K Buy
2,095
+15
+0.7% +$4.41K 0.31% 52
2024
Q1 		$591K Buy
2,080
+67
+3% +$19.6K 0.29% 55
2023
Q4 		$580K Buy
2,013
+39
+2% +$10.6K 0.34% 58
2023
Q3 		$531K Buy
1,974
+164
+9% +$40.9K 0.33% 60
2023
Q2 		$402K Sell
1,810
-100
-5% -$23.2K 0.25% 67
2023
Q1 		$458K Sell
1,910
-13,093
-87% -$3.21M 0.31% 60
2022
Q4 		$3.94M Buy
+15,003
New +$4.02M 2.95% 12

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Left Brain Wealth Management's AMGN Position: Q2 2026 in Review

Left Brain Wealth Management reduced its Amgen (AMGN) stake by 9.7% in Q2 2026, selling an estimated $59.2K and leaving 1,614 shares worth $584K. The position accounts for 0.18% of the portfolio, ranked #60.

Left Brain Wealth Management first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.94M in Q4 2022. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Left Brain Wealth Management held 1,614 shares of Amgen worth $584K as of Q2 2026.
  • Left Brain Wealth Management sold 173 Amgen shares in Q2 2026, an estimated $59.2K.
  • Amgen made up 0.18% of Left Brain Wealth Management's portfolio in Q2 2026, its #60 holding.
  • Left Brain Wealth Management first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • Left Brain Wealth Management's Amgen position peaked at $3.94M in Q4 2022.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Left Brain Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.